Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer

ABSTRACT Objectives: Non-small cell lung cancer (NSCLC) is an incidental and aggressive type of cancer. Although curative treatment can be offered, the recurrence rate is relatively high. Identifying factors that have a prognostic impact may guide changes in the staging system and recommendations for adjuvant therapy. The aim of this study was to evaluate the impact of microvascular invasion on the 5-year overall survival (OS) of patients with resected NSCLC treated at a reference cancer center. Methods: This retrospective, observational cohort study included patients diagnosed with early-stage NSCLC (clinical stages I-IIIA), treated with curative-intent surgery at the Brazilian National Cancer Institute between 2010 and 2016. Results: The dataset comprised 91 surgical patients, mostly females and white, with a mean age of 62 years (range between 29-83). Cases were distributed as stages I, II, and III in 55%, 29%, and 16%. Adenocarcinoma was the predominant histological subtype (67%), and microvascular invasion was present in 25% of the patients. The 5-year OS probability was 60% (95% CI, 48.3-68.9). Among all characteristics, advanced stages (p = 0.001) and the presence of microvascular invasion (p< 0.001) were related to a worse 5-year OS. After adjusting for age group and pathological stage, the presence of microvascular invasion was associated with a 4-fold increased risk of death (HR 3.9, 95% CI, 1.9-8.2). Conclusion: The presence of microvascular invasion was an independent factor related to worse survival and, therefore, should be routinely assessed in resected specimens.

Saved in:
Bibliographic Details
Main Authors: Monteiro,Andreia Salarini, Araújo,Sérgio Ricardo de Carvalho, Araujo,Luiz Henrique, Souza,Mirian Carvalho de
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000300205
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1806-37132022000300205
record_format ojs
spelling oai:scielo:S1806-371320220003002052022-07-06Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancerMonteiro,Andreia SalariniAraújo,Sérgio Ricardo de CarvalhoAraujo,Luiz HenriqueSouza,Mirian Carvalho de non-small cell lung cancer thoracic surgery survival analysis microvascular invasion. ABSTRACT Objectives: Non-small cell lung cancer (NSCLC) is an incidental and aggressive type of cancer. Although curative treatment can be offered, the recurrence rate is relatively high. Identifying factors that have a prognostic impact may guide changes in the staging system and recommendations for adjuvant therapy. The aim of this study was to evaluate the impact of microvascular invasion on the 5-year overall survival (OS) of patients with resected NSCLC treated at a reference cancer center. Methods: This retrospective, observational cohort study included patients diagnosed with early-stage NSCLC (clinical stages I-IIIA), treated with curative-intent surgery at the Brazilian National Cancer Institute between 2010 and 2016. Results: The dataset comprised 91 surgical patients, mostly females and white, with a mean age of 62 years (range between 29-83). Cases were distributed as stages I, II, and III in 55%, 29%, and 16%. Adenocarcinoma was the predominant histological subtype (67%), and microvascular invasion was present in 25% of the patients. The 5-year OS probability was 60% (95% CI, 48.3-68.9). Among all characteristics, advanced stages (p = 0.001) and the presence of microvascular invasion (p< 0.001) were related to a worse 5-year OS. After adjusting for age group and pathological stage, the presence of microvascular invasion was associated with a 4-fold increased risk of death (HR 3.9, 95% CI, 1.9-8.2). Conclusion: The presence of microvascular invasion was an independent factor related to worse survival and, therefore, should be routinely assessed in resected specimens.info:eu-repo/semantics/openAccessSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia v.48 n.3 20222022-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000300205en10.36416/1806-3756/e20210283
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Monteiro,Andreia Salarini
Araújo,Sérgio Ricardo de Carvalho
Araujo,Luiz Henrique
Souza,Mirian Carvalho de
spellingShingle Monteiro,Andreia Salarini
Araújo,Sérgio Ricardo de Carvalho
Araujo,Luiz Henrique
Souza,Mirian Carvalho de
Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
author_facet Monteiro,Andreia Salarini
Araújo,Sérgio Ricardo de Carvalho
Araujo,Luiz Henrique
Souza,Mirian Carvalho de
author_sort Monteiro,Andreia Salarini
title Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_short Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_full Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_fullStr Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_full_unstemmed Impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
title_sort impact of microvascular invasion on 5-year overall survival of resected non-small cell lung cancer
description ABSTRACT Objectives: Non-small cell lung cancer (NSCLC) is an incidental and aggressive type of cancer. Although curative treatment can be offered, the recurrence rate is relatively high. Identifying factors that have a prognostic impact may guide changes in the staging system and recommendations for adjuvant therapy. The aim of this study was to evaluate the impact of microvascular invasion on the 5-year overall survival (OS) of patients with resected NSCLC treated at a reference cancer center. Methods: This retrospective, observational cohort study included patients diagnosed with early-stage NSCLC (clinical stages I-IIIA), treated with curative-intent surgery at the Brazilian National Cancer Institute between 2010 and 2016. Results: The dataset comprised 91 surgical patients, mostly females and white, with a mean age of 62 years (range between 29-83). Cases were distributed as stages I, II, and III in 55%, 29%, and 16%. Adenocarcinoma was the predominant histological subtype (67%), and microvascular invasion was present in 25% of the patients. The 5-year OS probability was 60% (95% CI, 48.3-68.9). Among all characteristics, advanced stages (p = 0.001) and the presence of microvascular invasion (p< 0.001) were related to a worse 5-year OS. After adjusting for age group and pathological stage, the presence of microvascular invasion was associated with a 4-fold increased risk of death (HR 3.9, 95% CI, 1.9-8.2). Conclusion: The presence of microvascular invasion was an independent factor related to worse survival and, therefore, should be routinely assessed in resected specimens.
publisher Sociedade Brasileira de Pneumologia e Tisiologia
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000300205
work_keys_str_mv AT monteiroandreiasalarini impactofmicrovascularinvasionon5yearoverallsurvivalofresectednonsmallcelllungcancer
AT araujosergioricardodecarvalho impactofmicrovascularinvasionon5yearoverallsurvivalofresectednonsmallcelllungcancer
AT araujoluizhenrique impactofmicrovascularinvasionon5yearoverallsurvivalofresectednonsmallcelllungcancer
AT souzamiriancarvalhode impactofmicrovascularinvasionon5yearoverallsurvivalofresectednonsmallcelllungcancer
_version_ 1756431178842243072